Company profile for Instil Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Instil Bio, Inc is a global, clinical-stage cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of cancer. We are building on the decades-long foundation of TIL efficacy in treating solid tumors, applying our cell therapy experience and TIL manufacturing platform to bring the promise of TIL therapy to patients in need. Instil Bio has research and cell therapy manufacturing facilities in Los ...
Instil Bio, Inc is a global, clinical-stage cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of cancer. We are building on the decades-long foundation of TIL efficacy in treating solid tumors, applying our cell therapy experience and TIL manufacturing platform to bring the promise of TIL therapy to patients in need. Instil Bio has research and cell therapy manufacturing facilities in Los Angeles, CA and Manchester, UK, with corporate offices in Dallas, TX.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Dallas, Texas
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/13/3187151/0/en/Instil-Bio-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/09/10/3147631/0/en/Instil-Bio-Announces-ImmuneOnco-s-Presentation-of-2510-Monotherapy-Data-in-Patients-with-2L-Squamous-NSCLC-at-the-2025-World-Conference-on-Lung-Cancer-WCLC.html

GLOBENEWSWIRE
10 Sep 2025

https://www.globenewswire.com/news-release/2025/08/13/3132376/0/en/Instil-Bio-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

GLOBENEWSWIRE
13 Aug 2025

https://www.fiercebiotech.com/biotech/instils-licensed-pd-l1xvegf-bispecific-shows-promise-china-instilling-hope-upcoming-us-test

FIERCE BIOTECH
31 Jul 2025

https://www.globenewswire.com/news-release/2025/07/02/3109003/0/en/Instil-Bio-Announces-U-S-F-D-A-Clearance-of-Investigational-New-Drug-IND-Application-for-AXN-2510-a-PD-L1xVEGF-Bispecific-Antibody-for-a-Phase-1-Trial-in-Relapsed-Refractory-Solid-.html

GLOBENEWSWIRE
02 Jul 2025

https://www.globenewswire.com/news-release/2025/06/11/3097434/0/en/Instil-Bio-Names-John-Maraganore-Ph-D-to-Board-Role-Supporting-the-Advancement-of-PD-L1xVEGF-Bispecific-Antibody-Program.html

GLOBENEWSWIRE
11 Jun 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty